Меню
Набор скоро начнётся NCT07167706

Sleep Difficulties After Loss: Exploring the Beneficial Effect of Brief Behavioral Therapy for Insomnia in a Sample of Bereaved Individuals

Без фазы С лечением Insomnia Insomnia Chronic Complicated Grief

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Brief Behavioral Therapy for Insomnia, Sleep Hygiene Therapy.
Кому может быть актуально
Состояния в реестре: Insomnia, Insomnia Chronic, Complicated Grief. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Дания
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Sleep Difficulties After Loss (SLEEPLOSS): Exploring the Beneficial Effect of Brief Behavioral Therapy for Insomnia in a Sample of Bereaved Individuals

Обзор

The goal of the study is to investigate whether a brief behavioral therapy for insomnia (BBTI) improves sleep in bereaved patients screened for insomnia compared to an active control group (sleep hygiene education). The study will also explore if BBTI improves symptoms of complicated grief. The investigators will recruit approximately 58 bereaved participants with insomnia.

Подробное описание

The study is a randomized controlled trial comparing the effect of a brief behavioral therapy for insomnia (BBTI) on insomnia with an active control group (sleep hygiene). Participants will be 58 bereaved individuals who experience insomnia. After baseline assessment, participants will be randomized to either BBTI or sleep hygiene (active control). Both groups will undergo post-treatment assessments as well as 3- and 6-months follow-up assessments. The primary outcomes will be insomnia assessed with the Insomnia Severity Index (ISI) and improvements in sleep quality using the Pittsburgh Sleep Quality Index (PSQI) and sleep parameters using the consensus sleep diary. The secondary outcome will be complicated grief reactions (CGR) using the Aarhus Prolonged Grief Disorder scale (A-PGDs, prolonged grief). the Center of Epidemiological Studies Depression Scale (CESD-10, depression), the General Anxiety Disorder-7 questionnaire (GAD-7; anxiety), and the short-form PTSD Checklist for DSM-5 (PCL-5; PTSD).

The study has the following aims and hypotheses:

PRIMARY AIM: To investigate whether BBTI improves sleep in bereaved patients screened for insomnia when compared to an active control group.

PRIMARY HYPOTHESIS: Compared with the active control group, participants receiving BBTI will show statistically significant reductions in insomnia using the ISI, as well as improvements in sleep quality using the PSQI and sleep parameters using the consensus sleep diary.

SECONDARY AIM: To explore whether BBTI improves CGR in bereaved patients screened for insomnia when compared to an active control group.

SECONDARY HYPOTHESIS: Compared with the active control group, participants receiving BBTI will show statistically significant reductions in CGR using the A-PGDs, the CESD-10, the GAD-7, and the PCL-5.

Вмешательства

  • Поведенческое Brief Behavioral Therapy for Insomnia
    BBTI is a multi-component intervention consisting of techniques from sleep restriction and stimulus control therapy. It targets behavioral elements of insomnia using four techniques: 1) reduce time in bed, 2) get up at the same time every day, 3) do not go to bed unless sleepy, and 4) do not stay in bed unless asleep.
  • Поведенческое Sleep Hygiene Therapy
    SHE consists of education on lifestyle factors (diet, exercise, substance use) and enviromental variables (noise, light, temperature) affecting sleep quality.

Первичные конечные точки

  • Insomnia Severity Index (ISI) [Срок оценки: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).]
Вторичные конечные точки (12)
  • Pittsburgh Sleep Quality Index (PSQI) [Срок оценки: Time Frame: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).]
  • Consensus Sleep Diary [Срок оценки: Time Frame: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).]
  • Morningness-Eveningness Questionnaire - Revised (MEQr) [Срок оценки: Time Frame: Time Frame: Baseline (week 0)]
  • Aarhus Prolonged Grief Disorder Scale (A-PGDs) [Срок оценки: Time Frame: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16) 6-months follow-up (approximately week 28).]
  • Center for Epidemiological Studies Depression Scale - 10 Item Version (CESD-10) [Срок оценки: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • Generalized Anxiety Disorder - 7 Item Scale (GAD-7) [Срок оценки: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • PTSD Checklist for DSM-5 - Short Form (PCL-5 - Short Form) [Срок оценки: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • My Grief [Срок оценки: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • The perceived stress scale (PSS) [Срок оценки: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • The Short-Form (12) Health Survey (SF-12) [Срок оценки: Time Frame: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • World Health Organization-Five Well-Being Index (WHO-5) [Срок оценки: Baseline (week 0), post-treatment (approximately week 4), 3-months follow-up (approximately week 16), 6-months follow-up (approximately week 28).]
  • NEO Personality Inventory - Revised (NEO-PI-R), Neuroticism Only [Срок оценки: Baseline (week 0)]

Критерии участия

Критерии включения

  • Age ≥18 years
  • Bereaved (experienced the death of a perceived loved one) ≥6 months ago
  • Insomnia: a score of >10 on the Insomnia Severity index (ISI) and/or meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for Insomnia Disorder

Критерии исключения

  • Other sleep disor-ders (sleep apnea, parasomnia, narcolepsy)
  • Use of drugs impacting sleep
  • Severe psychological or physical disorders that may confound sleep (symptoms of CGR allowed)
  • Neurodegenerative disorders
  • Shift work
  • Insufficient Danish proficiency
  • Previous experience with BBTI or cognitive behavioral therapy for insomnia (CBT-I)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Лечение

Центры проведения

Дания · 1 центр
  • Aarhus University — Aarhus

Идентификаторы

NCT: NCT07167706 · 116242

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗